Event Details

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

KemPharm First Quarter 2017 Corporate Update Call

May 10, 2017 from 4:30 PM to 4:30 PM EDT